Cargando…
Tacrolimus Levels Are Not Associated with Risk of Malignancy in Lung Transplant Recipients
BACKGROUND: Lung transplant (LTx) recipients suffer from high rates of malignancy. Exposure to immunosuppressive medication such as tacrolimus has been proposed as a risk factor for tumorigenesis. We hypothesized that chronically high levels of tacrolimus would be associated with risk of malignancy....
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Scientific Literature, Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248030/ https://www.ncbi.nlm.nih.gov/pubmed/29133776 http://dx.doi.org/10.12659/AOT.904417 |